Catalyst Wire Dossier Catalyst Wire Dossier

FEBUXOSTAT

Febuxostat · HEC Pharm USA Inc.
Drug timelines are a Plus or Pro feature.

67 regulatory and trial events tracked for FEBUXOSTAT, covering 2009-01-13 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients [Phase 3]

See pricing